Transplantation for liver failure in patients with sickle cell disease: Challenging but feasible

Liver Transplantation

Volumn 17, Issue 4, 2011, Pages 381-392

  Hurtova, Monika ^a   Bachir, Dora ^b   Lee, Ketty ^b   Calderaro, Julien ^b   Decaens, Thomas ^a   Kluger, Michael D ^a   Zafrani, Elie Serge ^b   Cherqui, Daniel ^a   Mallat, Ariane ^a   Galactéros, Frédéric ^b   Duvoux, Christophe ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; HEMOGLOBIN S;

ACUTE LIVER FAILURE; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HUMAN; IRON OVERLOAD; LEUKOENCEPHALOPATHY; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; SICKLE CELL ANEMIA; SURVIVAL RATE;

ADULT; ANEMIA, SICKLE CELL; FEMALE; HUMANS; LIVER; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 79953165753     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22257     Document Type: Article

References (42)

1. Association Française de Dépistage et de Prévention des Handicaps de l'Enfant. Rapport d'Activité: Paris, France 2008.
2. Ballas SK, Lieff S, Benjamin LJ, Dampier CD, Heeney MM, Hoppe C, et al. Definitions of phenotypic manifestations of sickle cell disease. Am J Hematol 2010; 85: 6-13.
3. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W,. Mortality in children and adolescents with sickle cell disease. Pediatrics 1989; 84: 500-508. (Pubitemid 19216350)
4. Perronne V, Roberts-Harewood M, Bachir D, Roudot-Thoraval F, Delord JM, Thuret I, et al. Patterns of mortality in sickle cell disease in adults in France and England. Hematol J 2002; 3: 56-60. (Pubitemid 34223917)
5. Yanni E, Grosse SD, Yang Q, Olney RS,. Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002. J Pediatr 2009; 154: 541-545.
6. Johnson CS, Omata M, Tong MJ, Simmons JF, Weiner J, Tatter D,. Liver involvement in sickle cell disease. Medicine 1985; 64: 349-356. (Pubitemid 16224050)
7. Banerjee S, Owen C, Chopra S,. Sickle cell hepatopathy. Hepatology 2001; 33: 1021-1028. (Pubitemid 32378197)
8. Shao SH, Orringer EP,. Sickle cell intrahepatic cholestasis: approach to a difficult problem. Am J Gastroenterol 1995; 90: 2048-2050.
9. Schubert TT,. Hepatobilary system in sickle cell disease. Gastroenterology 1986; 90: 2013-2021. (Pubitemid 16085613)
10. Ahn H, Li CS, Wang W,. Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients. Pediatr Blood Cancer 2005; 45: 184-190. (Pubitemid 40993585)
11. Baichi MM, Arifuddin RM, Mantry PS, Bozorgzadeh A, Ryan C,. Liver transplantation in sickle cell anemia: a case of acute sickle cell intrahepatic cholestasis and a case of sclerosing cholangitis. Transplantation 2005; 80: 1630-1632. (Pubitemid 43005875)
12. Emre S, Kitibayashi K, Schwartz ME, Ahn J, Birnbaum A, Thung SN, Miller CM,. Liver transplantation in a patient with acute liver failure due to sickle cell intrahepatic cholestasis. Transplantation 2000; 69: 675-676. (Pubitemid 30129609)
13. Gilli SC, Boin IF, Sergio Leonardi L, Luzo AC, Costa FF, Saad ST,. Liver transplantation in a patient with S(beta)o-thalassemia. Transplantation 2002; 74: 896-898.
14. Kindscher JD, Laurin J, Delcore R, Forster J,. Liver transplantation in a patient with sickle cell anemia. Transplantation 1995; 60: 762-764.
15. Lang T, Berquist WE, So SK, Cox KL, Rich EJ, Vichinsky E, Concepcion W, Esquivel CO,. Liver transplantation in a child with sickle cell anemia. Transplantation 1995; 59: 1490-1492.
16. van den Hazel SJ, Metselaar HJ, Tilanus HW, IJzermans JN, Groenland TH, Visser L, de Man RA,. Successful liver transplantation in a patient with sickle-cell anaemia. Transpl Int 2003; 16: 434-436. (Pubitemid 36828168)
17. Lerut JP, Claeys N, Laterre PF, Lavenne-Pardonge E, Ciccarelli O, Cavallaro S, et al. Hepatic sickling: an unusual cause of liver allograft dysfunction. Transplantation 1999; 67: 65-68. (Pubitemid 29061138)
18. Ross AS, Graeme-Cook F, Cosimi AB, Chung RT,. Combined liver and kidney transplantation in a patient with sickle cell disease. Transplantation 2002; 73: 605-608. (Pubitemid 34193624)
19. Mekeel KL, Langham MR Jr, Gonzalez-Peralta R, Fujita S, Hemming AW,. Liver transplantation in children with sickle cell disease. Liver Transpl 2007; 13: 505-508. (Pubitemid 46605851)
20. Friedman LS,. Liver transplantation for sickle cell hepatopathy. Liver Transpl 2007; 13: 483-485. (Pubitemid 46605848)
21. Bernuau J, Rueff B, Benhamou JP,. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986; 6: 97-106. (Pubitemid 16010551)
22. Charlotte F, Bachir D, Nénert M, Mavier P, Galactéros F, Dhumeaux D, Zafrani ES,. Vascular lesions of the liver in sickle cell disease. Arch Pathol Lab Med 1995; 119: 46-52.
23. Bedossa P, Poynard T,. Algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-293. (Pubitemid 26260021)
24. European Liver Transplant Registry. Accessed December 2010.
25. Voskaridou E, Douskou M, Terpos E, Stamoulakatou A, Meletis J, Ourailidis A, et al. Deferiprone as an oral iron chelator in sickle cell disease. Ann Hematol 2005; 84: 434-440. (Pubitemid 40867919)
26. Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood 2010; 115: 2354-2363.
27. Little JA, McGowan VR, Kato GJ, Partovi KS, Feld JJ, Maric I, et al. Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. Haematologica 2006; 91: 1076-1083. (Pubitemid 44204773)
28. Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, Bertrand Y, et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007; 110: 2749-2756. (Pubitemid 47523201)
29. Gray A, Anionwu EN, Davies SC, Brozovic M,. Patterns of mortality in sickle cell disease in the United Kingdom. J Clin Pathol 1991; 44: 459-463.
30. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP,. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-1644.
31. DeVault KR, Friedman LS, Westerberg S, Martin P, Hosein B, Ballas SK,. Hepatitis C in sickle cell anemia. J Clin Gastroenterol 1994; 18: 206-209. (Pubitemid 24114434)
32. Hasan MF, Marsh F, Posner G, Bellevue R, Dosik H, Suatengco R, Ramani N,. Chronic hepatitis C in patients with sickle cell disease. Am J Gastroenterol 1996; 91: 1204-1206. (Pubitemid 26175483)
33. Ikura Y, Morimoto H, Johmura H, Fukui M, Sakurai M,. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am J Gastroenterol 1996; 91: 1367-1373. (Pubitemid 26236372)
34. Fong TL, Han SH, Tsai NC, Morgan TR, Mizokami M, Qian D, et al. A pilot randomised, controlled trial of the effect of iron depletion on long term response to alpha-interferon in patients with chronic hepatitis C. J Hepatol 1998; 28: 369-374. (Pubitemid 28133538)
35. Roche B, Sebagh M, Canfora ML, Antonini T, Roque-Afonso AM, Delvart V, et al. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis. Liver Transpl 2008; 14: 1766-1777.
36. Carriõn JA, Navasa M, García-Retortillo M, García-Pagan JC, Crespo G, Bruguera M, et al. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. Gastroenterology 2007; 132: 1746-1756. (Pubitemid 46695723)
37. Bizollon T, Pradat P, Mabrut JY, Radenne S, Ducerf C, Baulieux J, et al. Histological benefit of retreatment by pegylated interferon alfa-2b and ribavirin in patients with recurrent hepatitis C virus infection post-transplantation. Am J Transplant 2007; 7: 448-453. (Pubitemid 46096339)
38. Ancel D, Amiot X, Chaslin-Ferbus D, Hagege I, Garioud A, Girot R, et al. Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin. Eur J Gastroenterol Hepatol 2009; 21: 726-729.
39. Swaim MW, Agarwal S, Rosse WF,. Successful treatment of hepatitis C in sickle-cell disease. Ann Intern Med 2000; 133: 750-751.
40. Ayyub MA, El-Moursy SA, Khazindar AM, Abbas FA,. Successful treatment of chronic hepatitis C virus infection with peginterferon alpha-2a and ribavirin in patients with sickle cell disease. Saudi Med J 2009; 30: 712-716.
41. Neuberger J,. Incidence, timing, and risk factors for acute and chronic rejection. Liver Transpl Surg 1999; 5: S30-S36. (Pubitemid 29321234)
42. Hong JC, Kosari K, Benjamin E, Duffy JP, Ghobrial RM, Farmer DG, et al. Does race influence outcomes after primary liver transplantation? A 23-year experience with 2,700 patients. J Am Coll Surg 2008; 206: 1009-1016. (Pubitemid 351626988)